Evidence map›Paper›PMID 16029487›Full record

ArticleBMC cancer2005

Recovery of NIS expression in thyroid cancer cells by overexpression of Pax8 gene.

Ivan Presta, Franco Arturi, Elisabetta Ferretti, Tiziana Mattei, Daniela Scarpelli, Emanuele Tosi, Angela Scipioni, Marilena Celano, Alberto Gulino, Sebastiano Filetti and 1 more

Open access · goldAbstract read
In one paragraph

Article in BMC cancer, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. The Genetic Duet ofJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2020
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Anaplastic thyroid cancer, tumorigenesis and therapy.Irish journal of medical science · 2010
    Review
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Ivan PrestaDipartimento di Medicina Sperimentale e Clinica G. Salvatore, University of Catanzaro Magna Graecia, Catanzaro, Italy. presta@unicz.it
Franco Arturi
Elisabetta Ferretti
Tiziana Mattei
Daniela Scarpelli
Emanuele Tosi
Angela Scipioni
Marilena Celano
Alberto Gulino
Sebastiano Filetti
Diego Russo
Sapienza University of Rome · ITMagna Graecia University · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRecovery of iodide uptake in thyroid cancer cells by means of obtaining the functional expression of the sodium/iodide symporter (NIS) represents an innovative strategy for the treatment of poorly differentiated thyroid cancer. However, the NIS gene expression alone is not always sufficient to restore radioiodine concentration ability in these tumour cells.

methodsIn this study, the anaplastic thyroid carcinoma ARO cells were stably transfected with a Pax8 gene expression vector. A quantitative RT-PCR was performed to assess the thyroid specific gene expression in selected clones. The presence of NIS protein was detected by Western blot and localized by immunofluorescence. A iodide uptake assay was also performed to verify the functional effect of NIS induction and differentiation switch.

resultsThe clones overexpressing Pax8 showed the re-activation of several thyroid specific genes including NIS, Pendrin, Thyroglobulin, TPO and TTF1. In ARO-Pax8 clones NIS protein was also localized both in cell cytoplasm and membrane. Thus, the ability to uptake the radioiodine was partially restored, associated to a high rate of efflux. In addition, ARO cells expressing Pax8 presented a lower rate of cell growth.

conclusionThese finding demonstrate that induction of Pax8 expression may determine a re-differentiation of thyroid cancer cells, including a partial recovery of iodide uptake, fundamental requisite for a radioiodine-based therapeutic approach for thyroid tumours.

Indexed as

Gene Expression Regulation, NeoplasticBlotting, WesternCell Line, TumorCell ProliferationCytoplasmDNA PrimersGenetic VectorsHumansIodidesIodine RadioisotopesMembrane Transport ProteinsMicroscopy, FluorescencePaired Box Transcription FactorsPAX8 Transcription FactorPlasmidsRecombinant ProteinsDNA PrimersIodidesIodine RadioisotopesMembrane Transport ProteinsPaired Box Transcription FactorsPAX8 protein, humanPAX8 Transcription FactorRecombinant ProteinsRNARNA, MessengerSLC26A4 protein, humanSodium-Iodide SymportersSulfate TransportersSymportersThyroglobulin

Identifiers

PMID16029487
PMCPMC1180821
OpenAlexW1483345117

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.